Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection.
- Published in:
- PLoS Pathogens, 2023, v. 19, n. 11, p. 1, doi. 10.1371/journal.ppat.1011719
- By:
- Publication type:
- Article
Works by Kocak, Brian R.
Results: 2
1
2
812-P: The Role of Industry and NIH/Academia in the Clinical Development of GLP-1 Agonists and SGLT2 Inhibitors.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-812-P
- By:
- Publication type:
- Article